Ticker Details
Humacyte, Inc. Common Stock
IPO Date:	November 30, 2020
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$233.12M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.17 | 4.01%
Avg Daily Range (30 D):	$0.06 | 6.35%
Avg Daily Range (90 D):	$0.05 | 5.48%

Institutional Daily Volume
Avg Daily Volume:	1.86M
Avg Daily Volume (30 D):	5.63M
Avg Daily Volume (90 D):	6.38M

Trade Size
Avg Trade Size (Sh.):	229
Avg Trade Size (Sh.) (30 D):	396
Avg Trade Size (Sh.) (90 D):	465

Institutional Trades
Total Institutional Trades:	306
Avg Institutional Trade:	$1.47M
Avg Institutional Trade (30 D):	$.8M
Avg Institutional Trade (90 D):	$.84M
Avg Institutional Trade Volume:	.35M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.58M
Avg Closing Trade (30 D):	$.93M
Avg Closing Trade (90 D):	$.93M
Avg Closing Volume:	346.69K

News

May 13, 2026 @ 11:00 AM Humacyte Announces First Quarter 2026 Financial Re... Source: Na

May 12, 2026 @ 12:00 PM Humacyte Appoints Dr. Todd E. Rasmussen as Chief S... Source: Humacyte, Inc.

Mar 27, 2026 @ 11:00 AM Humacyte Announces Fourth Quarter and Year End 202... Source: Na

Dec 22, 2025 @ 1:00 PM Humacyte Announces Publication of Long-Term Safety... Source: Na

Nov 12, 2025 @ 4:00 PM Strong Earnings and Biotech Resilience Define the ... Source: Na

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.09	$-.15	$-.26
Diluted EPS	$-.09	$-.15	$-.26
Revenue	$.5M	$.47M	$2.04M
Gross Profit	$-1.54M	$-8.62M	$-7.66M
Net Income / Loss	$-17.62M	$-24.8M	$-40.83M
Operating Income / Loss	$-28.94M	$-30.84M	$-108.14M
Cost of Revenue	$2.04M	$9.08M	$9.7M
Net Cash Flow	$-1.96M	$31.01M	$-44.44M
PE Ratio